In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 |
Cost of goods sold | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross margin | 44.1% | | | | |
Selling, general and administrative [+] | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Sales and marketing | 0.7 | | | | |
General and administrative [+] | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
General and administrative expenses | 0.4 | 0.0 | | | |
Professional fees | | | 0.0 | 0.0 | 0.0 |
Other operating expenses | 0.0 | | 0.0 | 0.0 | 0.0 |
EBITDA [+] | -0.8 | | | | |
EBITDA growth | 4440.2% | -46.6% | -20.5% | 71.2% | |
EBITDA margin | -100.0% | | | | |
Depreciation and amortization | 0.0 | | | | |
EBIT [+] | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 |
EBIT growth | 4655.8% | -46.6% | -20.5% | 71.2% | |
EBIT margin | -104.8% | | | | |
Non-recurring items [+] | | | | | 0.0 |
Legal settlement | | | | | 0.0 |
Interest expense | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Interest expense | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Other income (expense), net [+] | -0.7 | 0.0 | | | |
Amortization of debt discount premium | 0.7 | | | | |
Gain (loss) on debt retirement | 0.0 | | | | |
Gain (loss) on derivative instruments | -0.1 | | | | |
Other | 0.7 | | | | |
Pre-tax income | -1.6 | 0.0 | 0.0 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -1.6 | 0.0 | 0.0 | 0.0 | 0.0 |
Net margin | -211.9% | | | | |
|
Basic EPS [+] | ($0.03) | $0.00 | $0.00 | $0.00 | $0.00 |
Growth | 5761.6% | -34.9% | -11.4% | 44.8% | |
Diluted EPS [+] | ($0.03) | $0.00 | $0.00 | $0.00 | $0.00 |
Growth | 5761.6% | -34.9% | -11.4% | 44.8% | |
|
Shares outstanding (basic) [+] | 47.5 | 44.1 | 44.1 | 44.1 | 44.1 |
Growth | 7.6% | 0.0% | 0.0% | 0.0% | |
Shares outstanding (diluted) [+] | 47.5 | 44.1 | 44.1 | 44.1 | 44.1 |
Growth | 7.6% | 0.0% | 0.0% | 0.0% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |